cubeRandom

Resistance to Anti-Cancer Therapy

Our goal is to elucidate mechanisms of resistance to current anti-cancer therapies, such as hormone therapy for prostate cancer.

cubeRandom

Novel Biomarkers

We aim to identify novel biomarkers for hormone-therapy response via CRISPR/shRNA-based library screens.

cubeRandom

Combination Therapies

We seek to determine the molecular mechanism of lineage-plasticity-driven resistance and develop combination therapies to overcome it.

cubeRandom

Cancer Cell Lineage Plasticity

We have identified a novel mechanism of antiandrogen resistance in prostate cancer driven by lineage plasticity, or “identity fraud."